HAM
SUPN icon

Highstreet Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Highstreet Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
36
– – ﹤0.01% 641
2019
Q3 		$1K Hold
36
– – ﹤0.01% 408
2019
Q2 		$1K Hold
36
– – ﹤0.01% 409
2019
Q1 		$1K Hold
36
– – ﹤0.01% 411
2018
Q4 		$1K Sell
36
-24
-40% -$1.03K ﹤0.01% 388
2018
Q3 		$3K Buy
+60
New +$2.96K ﹤0.01% 343

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Highstreet Asset Management's SUPN Position: Q4 2019 in Review

Highstreet Asset Management held its Supernus Pharmaceuticals (SUPN) position steady in Q4 2019 at 36 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Highstreet Asset Management first reported a position in SUPN in Q3 2018 and has held it in 6 quarters since. The position peaked at $3K in Q3 2018. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2019.

  • Highstreet Asset Management held 36 shares of Supernus Pharmaceuticals worth $1K as of Q4 2019.
  • Highstreet Asset Management left its Supernus Pharmaceuticals share count unchanged in Q4 2019.
  • Supernus Pharmaceuticals made up ﹤0.01% of Highstreet Asset Management's portfolio in Q4 2019, its #641 holding.
  • Highstreet Asset Management first reported a position in Supernus Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
  • Highstreet Asset Management's Supernus Pharmaceuticals position peaked at $3K in Q3 2018.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.